Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Drug Deliv Transl Res. 2014 Apr 1;4(2):203–209. doi: 10.1007/s13346-013-0190-7

Table 2.

Plasma PTX concentrations following IP Taxol® or PTX/PEG-PSA

Treatment Time Plasma PTX concentration (μg/mL)
Taxol® 5 min 0
1 hr 3.2 ± 0.6
2 hr 5.2 ± 0.4
4 hr 1.9 ± 0.3
PTX/PEG-PSA 1 day 0.9 ± 0.1
7 days 1.2 ± 0.1
14 days 1.1 ± 0.1